Brain Stimulation and Enhancing Cognition in Older Adults



Status:Recruiting
Conditions:Anxiety, Anxiety, Depression
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:60 - Any
Updated:9/2/2018
Start Date:June 27, 2018
End Date:June 26, 2019
Contact:Hanadi Ajam Oughli, MD
Email:ajamoughli@wustl.edu
Phone:314-267-7801

Use our guide to learn which trials are right for you!

Enhancing Cognition in Older Persons: A Randomized Controlled Trial of Mindfulness-Based Stress Reduction (MBSR) and Transcranial Direct Current Stimulation (tDCS).

The aim of the current research is to evaluate the efficacy of a combination of
Mindfulness-Based Stress Reduction (MBSR) and transcranial direct current stimulation (tDCS)
to improve cognitive function in individuals with anxiety, depression and/or cognitive
complaints.

Neurocognitive difficulties are a common problem in the older adult population. Previous
research has shown memory complaints are higher in older adults with depression or anxiety
versus those without these diagnoses. This suggests that mood symptoms, or a diagnosis of a
mood disorder, may represent significant predictors of cognitive impairment. If left
untreated, symptoms of depression and memory complaints may lead to greater cognitive
impairment, i.e. Mild Cognitive Impairment (MCI) and diagnosis of dementia. Therefore, early
interventions are urgently needed to prevent decline in memory and cognitive function in
individuals with MCI, depression and/or anxiety.

Ideal interventions for the older aged population would be those that are easily accessible
and associated with minimal burden on family members, the healthcare system and the
individuals themselves. Mindfulness- Based Stress Reduction (MBSR) therapy and Transcranial
Direct Current Stimulation (tDCS) are two interventions that may be effective in targeting
cognitive deficits in individuals with anxiety, depression and/ or cognitive complaints. MBSR
has been shown to decrease symptoms of depression and improve cognition and tDCS has been
shown to improve cognition in the older aged population. The effectiveness of these two
interventions combined to elicit changes in cognition has yet to be demonstrated. Therefore,
the overall aim of the current research is to evaluate the efficacy of a combination of MBSR
and tDCS to improve cognitive function in individuals with anxiety, depression and/or
cognitive complaints.

This will be a randomized pilot study. Sixteen individuals (separated into 2 groups of 8)
will be randomized to receive a combination of MBSR + active tDCS or MBSR + sham tDCS over 8
weeks. Participants will visit the Healthy Mind Lab once per week for in-class group sessions
and will complete the intervention daily at home for the duration of the study. Participants
will be aged 60 and older with cognitive complaints, with or without symptoms of anxiety
and/or depression. Participants will be trained to self-administer tDCS and given guidelines
for the completion of daily MBSR activities at home. It is hypothesized that the combination
of active tDCS+MBSR will enhance cognition compared to the combination of sham tDCS + MBSR.

Inclusion Criteria:

1. Community-dwelling men and women aged 60 or above.

2. Current cognitive complaints per participant self-report, but with intact cognitive
function as defined by a score of 0-9 on the Short Blessed Test (SBT) and a Montreal
Cognitive Assessment (MoCA) score ≥25 per PI discretion.

3. PROMIS depression scale score of greater or equal to 16 and/or PROMIS anxiety score
greater or equal to 14.

4. Ability to read and speak English fluently enough to complete all research
assessments.

5. Corrected visual ability to read newspaper headlines.

6. Hearing capacity to respond to a raised conversational voice.

7. Willingness and ability to provide informed consent.

Exclusion Criteria:

1. The Mini-International Neuropsychiatric Interview (MINI) criteria for current or
life-time bipolar disorder, schizophrenia, schizoaffective disorder.

2. Untreated current post-traumatic stress disorder.

3. A MoCA score <25 or SBT score >9, per PI discretion.

4. Use of cognitive enhancers (namely, cholinesterase inhibitors such as donepezil; or
memantine) within the past 6 weeks.

5. MINI criteria for any substance abuse within 6 months that would affect their
participation, per PI discretion.

6. Unstable medical illness (e.g. uncontrolled diabetes mellitus or hypertension).

7. Concurrent cognitive training, such as brain-training software, participation in
psychotherapy or regular engagement in mindfulness practice and/or yoga.

8. Taking anticonvulsant or antipsychotics that cannot be safely tapered and
discontinued.
We found this trial at
2
sites
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Eric Lenze
Phone: 314-362-6400
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Phone: 314-267-7801
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials